Angiodynamics Overview
- Year Founded
-
1988
- Status
-
Public
- Employees
-
632
- Stock Symbol
-
ANGO
- Investments
-
15
- Share Price
-
$10.76
- (As of Thursday Closing)
Angiodynamics General Information
Description
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
Contact Information
Website
www.angiodynamics.comCorporate Office
- 14 Plaza Drive
- Latham, NY 12110
- United States
Corporate Office
- 14 Plaza Drive
- Latham, NY 12110
- United States
Angiodynamics Stock Performance
As of 19-Nov-2026, Angiodynamics’s stock price is $10.76. Its current market cap is $453M with 42.1M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.76 | $11.32 | $9.39 - $16.29 | $453M | 42.1M | 647K | -$0.78 |
Angiodynamics Financials Summary
As of 31-Aug-2026, Angiodynamics has a trailing 12-month revenue of $325M.
|
In Thousands, USD |
TTM 31-Aug-2026 | FY 2026 31-May-2026 | FY 2025 31-May-2025 | FY 2024 31-May-2024 |
|---|---|---|---|---|
| EV | 612,827 | 436,531 | 374,431 | 174,293 |
| Revenue | 325,378 | 320,174 | 292,498 | 303,914 |
| EBITDA | (9,872) | (13,046) | (9,210) | (165,540) |
| Net Income | (32,936) | (36,742) | (33,993) | (184,349) |
| Total Assets | 241,933 | 267,163 | 280,144 | 317,671 |
| Total Debt | 0 | 0 | 0 | 4,728 |
Angiodynamics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Angiodynamics Comparisons
Industry
Financing
Details
Angiodynamics Competitors (48)
One of Angiodynamics’s 48 competitors is Merit Medical Systems, a Corporation company based in South Jordan, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merit Medical Systems | Corporation | South Jordan, UT | ||||
| Penumbra | Formerly VC-backed | Alameda, CA | ||||
| ShockWave Medical | Formerly VC-backed | Santa Clara, CA | ||||
| Inari Medical | Formerly VC-backed | Irvine, CA | ||||
| Teleflex | Corporation | Wayne, PA |
Angiodynamics Patents
Angiodynamics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1084316-S1 | Ferrule | Active | 20-Nov-2023 | ||
| US-20250025189-A1 | Aspiration systems and methods for removal of undesired material from a circulatory system | Pending | 20-Jul-2023 | ||
| US-20240148956-A1 | Filter for mechanical thrombectomy device and method of using the same | Pending | 07-Nov-2022 | ||
| US-20230149073-A1 | Method and device for probe navigation of an ablation system | Pending | 15-Nov-2021 | ||
| US-20230030606-A1 | Device and method of use for aspiration system retrievers | Pending | 20-Jul-2021 | A61B17/221 |
Angiodynamics Signals
Angiodynamics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Angiodynamics Investments & Acquisitions (15)
Angiodynamics’s most recent deal was a Corporate Asset Purchase with QX Medical (Camaro Support Catheter Asset) for . The deal was made on 27-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| QX Medical (Camaro Support Catheter Asset) | 27-Jul-2021 | Corporate Asset Purchase | Buildings and Property | ||
| AngioDynamics (PICC, Midline, and Tip Location Product) | 17-Dec-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Eximo | 02-Oct-2019 | Merger/Acquisition | Therapeutic Devices | ||
| RadiaDyne | 21-Sep-2018 | Merger/Acquisition | Therapeutic Devices | ||
| Surgical Specialties (BioSentry Tract Sealant System) | 14-Aug-2018 | Corporate Asset Purchase | Other Devices and Supplies |
Angiodynamics ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.88 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Angiodynamics Exits (4)
Angiodynamics’s most recent exit was on 17-Dec-2020 from AngioDynamics (PICC, Midline, and Tip Location Product). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| AngioDynamics (PICC, Midline, and Tip Location Product) | 17-Dec-2020 | Completed |
|
||
| Merz (Distribution rights of Asclera) | 10-Mar-2016 | Completed |
|
||
| EmboMedics | 01-Apr-2015 | Completed |
|
||
| AngioCare | 01-Jan-2011 | Merger/Acquisition | Completed |
Angiodynamics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Diomed | Andover, MA | 1997 |
Angiodynamics FAQs
-
When was Angiodynamics founded?
Angiodynamics was founded in 1988.
-
Where is Angiodynamics headquartered?
Angiodynamics is headquartered in Latham, NY.
-
What is the size of Angiodynamics?
Angiodynamics has 632 total employees.
-
What industry is Angiodynamics in?
Angiodynamics’s primary industry is Surgical Devices.
-
Is Angiodynamics a private or public company?
Angiodynamics is a Public company.
-
What is Angiodynamics’s stock symbol?
The ticker symbol for Angiodynamics is ANGO.
-
What is the current stock price of Angiodynamics?
As of 19-Nov-2026 the stock price of Angiodynamics is $10.76.
-
What is the current market cap of Angiodynamics?
The current market capitalization of Angiodynamics is $453M.
-
What is Angiodynamics’s current revenue?
The trailing twelve month revenue for Angiodynamics is $325M.
-
Who are Angiodynamics’s competitors?
Merit Medical Systems, Penumbra, ShockWave Medical, Inari Medical, and Teleflex are some of the 48 competitors of Angiodynamics.
-
What is Angiodynamics’s annual earnings per share (EPS)?
Angiodynamics’s EPS for 12 months was -$0.78.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process